ynngy
2021-04-13
nooo
Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么Canopy Growth、Aurora Cannabis和Hexo股票周一上涨</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
4
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":345358733,"tweetId":"345358733","gmtCreate":1618281253222,"gmtModify":1634293968582,"author":{"id":3575273190676019,"idStr":"3575273190676019","authorId":3575273190676019,"authorIdStr":"3575273190676019","name":"ynngy","avatar":"https://static.tigerbbs.com/c3b764c34a3be814280b5ed823bbb9c7","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>nooo</p></body></html>","htmlText":"<html><head></head><body><p>nooo</p></body></html>","text":"nooo","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/345358733","repostId":1151812879,"repostType":4,"repost":{"id":"1151812879","kind":"news","pubTimestamp":1618279758,"share":"https://www.laohu8.com/m/news/1151812879?lang=zh_CN&edition=full","pubTime":"2021-04-13 10:09","market":"us","language":"en","title":"Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么Canopy Growth、Aurora Cannabis和Hexo股票周一上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1151812879","media":"Motley Fool","summary":"Blame Aphria.\nWhat happened\nIt's Monday, and marijuana stocks are vaporizing.Canopy Growth (NASDAQ:C","content":"<p>Blame Aphria.</p><p><blockquote>怪Aphria。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> It's Monday, and marijuana stocks are vaporizing.<b>Canopy Growth</b> (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals <b>Aurora Cannabis</b> (NYSE:ACB) and <b>Hexo</b> (NYSE:HEXO) have both tumbled about 9% each.</p><p><blockquote>今天是星期一,大麻股票正在蒸发。<b>冠层生长</b>(纳斯达克:CGC)股价下跌4.7%,大麻竞争对手<b>奥罗拉大麻</b>(纽约证券交易所代码:ACB)和<b>己糖</b>(NYSE:HEXO)均下跌约9%。</blockquote></p><p> And if you want to know why, ask <b>Aphria</b> (NASDAQ:APHA).</p><p><blockquote>如果你想知道为什么,问<b>Aphria</b>(纳斯达克:APHA)。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5780413b068fd57f09ff47950d68591b\" tg-width=\"2000\" tg-height=\"1333\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社。</span></p></blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.</p><p><blockquote>是的,尽管感觉不公平,但Canopy、Aurora和Hexo今天下跌的罪魁祸首并不是上述股票,而是他们的大麻种植竞争对手Aphria,该公司今天上午公布了2021年第三季度财报。</blockquote></p><p> Suffice it to say that the news was not good.</p><p><blockquote>我只想说这个消息不好。</blockquote></p><p> Sales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.</p><p><blockquote>这家加拿大大麻公司的销售额在2021年第三季度增长了6%,达到1.536亿加元,但远低于分析师预测的1.662亿加元。更糟糕的是,Aphria报告本季度每股亏损1.14加元,而一年前报告的利润微薄(根据公认会计原则或GAAP计算)。以美元计,Aphria每股亏损0.91美元。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Aphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.</p><p><blockquote>Aphria将其令人失望的业绩归咎于“我们运营的许多地区,特别是加拿大的封锁持续时间和影响”,但坚称其“凭借我们的领先品牌和市场份额仍然处于有利地位,可以实现强劲增长”随着市场的改善,我们的营收”,并表示仍然“对增量增长的战略机会感到兴奋”,特别是在美国市场。</blockquote></p><p> Regardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.</p><p><blockquote>无论如何,Aphria本季度销售毛利润下降近一半的事实表明,对该产品的需求不一定是Aphria(或Canopy、Aurora或Hexo)未来最大的问题。销售增长带来的利润萎缩表明该行业的定价能力下降,因为供应过剩继续影响医用大麻和休闲大麻的盈利能力。</blockquote></p><p> That's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.</p><p><blockquote>这对Aphria的未来来说不是好消息。这对Canopy Growth、Aurora Cannabis或Hexo来说也不是好消息。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么Canopy Growth、Aurora Cannabis和Hexo股票周一上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Canopy Growth, Aurora Cannabis, and Hexo Stocks Went Up in Smoke Monday<blockquote>为什么Canopy Growth、Aurora Cannabis和Hexo股票周一上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-04-13 10:09</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Blame Aphria.</p><p><blockquote>怪Aphria。</blockquote></p><p> <b>What happened</b></p><p><blockquote><b>发生了什么</b></blockquote></p><p> It's Monday, and marijuana stocks are vaporizing.<b>Canopy Growth</b> (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals <b>Aurora Cannabis</b> (NYSE:ACB) and <b>Hexo</b> (NYSE:HEXO) have both tumbled about 9% each.</p><p><blockquote>今天是星期一,大麻股票正在蒸发。<b>冠层生长</b>(纳斯达克:CGC)股价下跌4.7%,大麻竞争对手<b>奥罗拉大麻</b>(纽约证券交易所代码:ACB)和<b>己糖</b>(NYSE:HEXO)均下跌约9%。</blockquote></p><p> And if you want to know why, ask <b>Aphria</b> (NASDAQ:APHA).</p><p><blockquote>如果你想知道为什么,问<b>Aphria</b>(纳斯达克:APHA)。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5780413b068fd57f09ff47950d68591b\" tg-width=\"2000\" tg-height=\"1333\"><span>IMAGE SOURCE: GETTY IMAGES.</span></p><p><blockquote><p class=\"t-img-caption\"><span>图片来源:盖蒂图片社。</span></p></blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Yes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.</p><p><blockquote>是的,尽管感觉不公平,但Canopy、Aurora和Hexo今天下跌的罪魁祸首并不是上述股票,而是他们的大麻种植竞争对手Aphria,该公司今天上午公布了2021年第三季度财报。</blockquote></p><p> Suffice it to say that the news was not good.</p><p><blockquote>我只想说这个消息不好。</blockquote></p><p> Sales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.</p><p><blockquote>这家加拿大大麻公司的销售额在2021年第三季度增长了6%,达到1.536亿加元,但远低于分析师预测的1.662亿加元。更糟糕的是,Aphria报告本季度每股亏损1.14加元,而一年前报告的利润微薄(根据公认会计原则或GAAP计算)。以美元计,Aphria每股亏损0.91美元。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Aphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.</p><p><blockquote>Aphria将其令人失望的业绩归咎于“我们运营的许多地区,特别是加拿大的封锁持续时间和影响”,但坚称其“凭借我们的领先品牌和市场份额仍然处于有利地位,可以实现强劲增长”随着市场的改善,我们的营收”,并表示仍然“对增量增长的战略机会感到兴奋”,特别是在美国市场。</blockquote></p><p> Regardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.</p><p><blockquote>无论如何,Aphria本季度销售毛利润下降近一半的事实表明,对该产品的需求不一定是Aphria(或Canopy、Aurora或Hexo)未来最大的问题。销售增长带来的利润萎缩表明该行业的定价能力下降,因为供应过剩继续影响医用大麻和休闲大麻的盈利能力。</blockquote></p><p> That's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.</p><p><blockquote>这对Aphria的未来来说不是好消息。这对Canopy Growth、Aurora Cannabis或Hexo来说也不是好消息。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.fool.com/investing/2021/04/12/why-canopy-growth-aurora-cannabis-and-hexo-stocks/\">Motley Fool</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ACB":"奥罗拉大麻公司","CGC":"Canopy Growth Corporation","APHA":"Aphria Inc."},"source_url":"https://www.fool.com/investing/2021/04/12/why-canopy-growth-aurora-cannabis-and-hexo-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151812879","content_text":"Blame Aphria.\nWhat happened\nIt's Monday, and marijuana stocks are vaporizing.Canopy Growth (NASDAQ:CGC) stock is down a depressing 4.7%, and cannabis rivals Aurora Cannabis (NYSE:ACB) and Hexo (NYSE:HEXO) have both tumbled about 9% each.\nAnd if you want to know why, ask Aphria (NASDAQ:APHA).\nIMAGE SOURCE: GETTY IMAGES.\nSo what\nYes, unfair as it may feel, the stock to blame for Canopy's, Aurora's, and Hexo's declines today is none of the above, but rather their cannabis-growing rival Aphria, which reported itsfiscal Q3 2021earnings results this morning.\nSuffice it to say that the news was not good.\nSales at the Canadian cannabis company grew a respectable 6% to CA$153.6 million in Q3 2021, but that was well below the CA$166.2 million that analysts had predicted. Worse, Aphria reported a CA$1.14-per-share loss for the quarter, versus the tiny profit (calculated according to generally accepted accounting principles or GAAP) reported a year ago. In terms of U.S. dollars, Aphria lost $0.91 per share.\nNow what\nAphria blamed \"the duration and impact of lockdowns across many of the regions we operate in, particularly in Canada\" for its disappointing results, but insisted that it \"remains well-positioned with our leading brands and market share to experience a robust increase in our top-line as the market improves\" and said it is still \"excited about the strategic opportunities for incremental growth,\" particularly in the U.S. market.\nRegardless, the fact that Aphria's gross profits on its sales declined by nearly half in the quarter suggests that demand for the product isn't necessarily Aphria's (or Canopy's or Aurora's or Hexo's) biggest problem going forward. Shrinking profit on growing sales speaks to declining pricing power in the industry as oversupply continues to weigh on profitability for medical marijuana and recreational marijuana alike.\nThat's not good news for Aphria's future.It's not good news for Canopy Growth, Aurora Cannabis, or Hexo, either.","news_type":1,"symbols_score_info":{"APHA":0.9,"CGC":0.9,"ACB":0.9,"HEXO":0.9}},"isVote":1,"tweetType":1,"viewCount":488,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/345358733"}
精彩评论